Natural Health Products USA


 

PART 5 - DANISH ATHLETE STUDY:

GRAPHICAL DATA ON CARDIOVASCULAR RISK FACTORS


DATA TABLES & GRAPHS, NUMBERS 1 thru 8
(These are reference graphs supporting the discussion in PART 4)


DATA #1

 
After 59 days in 41 persons
After 57 days in a sub-group of 7
After 106 days in the same sub-group of 7
HDL-cholesterol
8.79%
14.65%
16.22%
HDL:LDL ratio
16.95%
20.55%
39.78%
TT4
-5.50%
n/a
n/a
total cholesterol
n/a
n/a
-6.70%
LDL-cholesterol
n/a
n/a
-15.04%
triglycerides
n/a
n/a
-20.73%


GRAPH #1

ChartObject Comparison of significant changes in cardiovascular risk factors


 DATA #2

Parameter Change n Significance
fasting glucose -6.64% 7 significant (P<0.025)
hemoglobin A1c 1.05% 7 not significant
Lp(a) 1.44% 7 not significant
fibrinogen -6.93% 7 not significant
triglycerides -20.73% 7 significant (P=0.0545)
total cholesterol -6.70% 7 significant (P=0.025)
HDL-cholesterol 16.22% 7 possibly significant (P=0.0897)
LDL-cholesterol -15.04% 7 significant (P=0.010)
HDL:LDL ratio 39.78% 7 significant (P=0.025)
       


GRAPH #2

ChartObject Changes in cardiovascular risk factors after 106 days of supplementation in the same sub-group of 7 participants

 


 DATA #3

Parameter Change n Validity
triglycerides -20.73% 7 significant (P=0.0545)
total cholesterol -6.70% 7 significant (P=0.025)
HDL-cholesterol 16.22% 7 possibly significant (P=0.0897)
LDL-cholesterol -15.04% 7 significant (P=0.010)
HDL:LDL ratio 39.78% 7 significant (P=0.025)
       
       

 

GRAPH #3

ChartObject Significant changes in cardiovascular risk factors after 106 days of supplementation in the same sub-group of 7 participants

 


 DATA #4

  Change n Validity
fasting glucose -2.43% 7 not significant
hemoglobin A1c -3.29% 7 not significant
Lp(a) 12.45% 7 not significant
fibrinogen 1.31% 7 not significant
triglycerides 12.53% 7 not significant
total cholesterol 3.43% 7 not significant
HDL-cholesterol 14.65% 7 significant (P=0.0391)
LDL-cholesterol -3.53% 7 not significant
HDL:LDL ratio 20.55% 7 significant (P=0.0514)
       
       

 

GRAPH #4

ChartObject Changes in cardiovascular risk factors after 57 days of supplementation in the sub-group of 7 participants


 


 DATA #5

Parameter
Change
n
Validity
HDL-cholesterol
14.65%
7
significant (P=0.0391)
HDL:LDL ratio
20.55%
7
significant (P=0.0514)


GRAPH #5

 

 


 DATA #6

 
Change (%)
n
Validity
fasting glucose
5.59%
41
not significant
hemoglobin A1c
1.31%
41
not significant
Lp(a)
2.72%
39
not significant
fibrinogen
-0.53%
40
not significant
triglycerides
-2.87%
41
not significant
total cholesterol
0.47%
41
not significant
HDL-cholesterol
8.79%
41
significant (P=0.011)
LDL-cholesterol
-1.08%
40
not significant
HDL:LDL ratio
16.95%
40
significant (P=0.053)
TSH
7.69%
9
not significant
TT4
-5.50%
9
significant (P=0.005)
TT3
-8.10%
9
not significant
TT3-reaction
2.28%
9
not significant
testosterone (males)
-14.20%
4
not significant
testosterone (females)
57.23%
5
not significant


GRAPH #6

ChartObject Changes in other parameters after 59 days of supplementation in 9 participants

 


 GRAPH #7

ChartObject Changes in cardiovascular risk factors after 59 days of supplementation in 41 participants


 DATA #8

Parameter
Change
n
Validity
HDL-cholesterol
8.79%
41
significant (P=0.011)
HDL:LDL ratio
16.95%
40
significant (P=0.053)
TT4
-5.50%
9
significant (P=0.005)

 

GRAPH #8

ChartObject Significant changes in measured parameters after 59 days of supplementation in 41 participants


 
Next   Index   Part 1   Part 2   Part 3   Part 4   Part 5   Part 6A   Part 6B   Part 6C   Part 7
 
 
 
 
 
 







Danish Athlete Study:
 
Products| Stores| Health Experts| Health Information| Complimentary Services| About Flora
Contact Us| International Home | Canada Home| USA Home| Flora Home
All text and Images © Flora Inc. The content on this site is meant for informational purposes only, and is not intended for use as official health consultation or recommendations. Flora Inc. takes no responsibility for harm that may result from the use, abuse or misuse of information contained on this site. Please read our Privacy Statement